KALOBIOS PHARMACEUTICALS INC 4
4 · KALOBIOS PHARMACEUTICALS INC · Filed Feb 18, 2015
Insider Transaction Report
Form 4
Yarranton Geoffrey Thomas
Chief Scientific Officer
Transactions
- Award
Stock Options (right to buy)
2015-02-16+300,000→ 300,000 totalExercise: $0.45Exp: 2025-02-15→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]1/4 of the option shares will vest and become exercisable on each 6-month anniversary of continuous service after February 16, 2015.